Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iluvien for Diabetic Macular Edema (FAD)
NCT02902744Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
A Phase 4 trial of fluocinolone in diabetic macular edema (DME), sponsored by Johns Hopkins University. Planned start Mar 2017; status: withdrawn.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02902744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02902744.